Lisata Therapeutics, Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 5.
AI score 5 (80% interval 5–6) · evidence grade D · US · Pharma / Chemicals
Stated reason: On August 3, 2026, the board of directors (the “Board”) of Lisata Therapeutics, Inc. (the “Company”) approved a reduction in workforce by approximately 72%, effective immediately. The decision was based on cost-reduction initiatives intended to reduce the Company’s ongoing operating expenses and maximize shareholder value as the Company plans to pursue strategic options. Affected employees will be offered separation …
Why 5: Merger / acquisition integration · Drivers: industry AI exposure +0.5, contrary evidence −0.2, role AI exposure +0.2
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.86, industry exposure 0.712, AI investment 0.0, contrary 0.15 · named roles: Computer and Information Systems Managers, General and Operations Managers, Market Research Analysts and Marketing Specialists, Marketing Managers, News Analyst
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
